Literature DB >> 27180928

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer.

Jinlin Cao1, Ping Yuan1, Honghai Ma1, Peng Ye1, Yiqing Wang1, Xiaoshuai Yuan1, Feichao Bao1, Wang Lv1, Jian Hu2.   

Abstract

BACKGROUND: The number of lymph node metastases (LNMs) and the positive lymph node ratio (LNR) have been shown to be significant independent prognostic factors in predicting overall survival in patients with esophageal cancer. Our aim was to evaluate whether a novel prognostic indicator-the log odds of positive lymph nodes (LODDS)-predicts survival in esophageal cancer.
METHODS: Patients who underwent esophagectomy for esophageal cancer between 1988 and 2007 were identified from the Surveillance, Epidemiology, and End Results (SEER) database of 18 registries, and a Chinese patient cohort was subjected to validation. The prognostic efficacy of LNM, LNR, and LODDS was compared. Prognostic performance was measured using Harrell's C-index statistic, Schemper's proportion of explained variation, and the Akaike information criterion (AIC).
RESULTS: A total of 4,123 patients in the SEER database and 134 patients in the Chinese cohort met our criteria in this study. LODDS gave a better prognostic performance than either LNM or LNR in both the SEER database and the Chinese cohort. Multivariate analyses showed significant values for LNM, LNR, and LODDS as prognostic factors (p < 0.001). However, only LODDS was a significant prognostic factor regardless of the number of lymph nodes retrieved (p = 0.677). Furthermore, after stratification of patients with no nodes involved or all nodes involved, the values of LODDS still distinguished the heterogeneity efficiently.
CONCLUSIONS: LODDS predicts survival more accurately than either LNM or LNR in patients undergoing resection for esophageal cancer, especially for patients with an insufficient number of lymph nodes retrieved.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27180928     DOI: 10.1016/j.athoracsur.2016.03.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

Review 1.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.

Authors:  Yuling Zhang; Ditian Liu; Chunfa Chen
Journal:  J Gastrointest Cancer       Date:  2021-09

3.  Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis.

Authors:  Yuming Zhao; Shengyi Zhong; Zhenhua Li; Xiaofeng Zhu; Feima Wu; Yanxing Li
Journal:  Oncotarget       Date:  2017-07-15

4.  Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method.

Authors:  Yunpeng Zhao; Shukang Zhao; Yingjie Chen; Xiaopeng Dong; Chuanliang Peng; Qifeng Sun; Lei Shan; Zhendan Wang; Xiaogang Zhao
Journal:  Oncol Lett       Date:  2019-02-06       Impact factor: 2.967

5.  Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage.

Authors:  Feng Wang; Shu-Geng Gao; Qi Xue; Feng-Wei Tan; Yu-Shun Gao; You-Sheng Mao; Da-Li Wang; Jun Zhao; Yin Li; Xiang-Yang Yu; Hong Cheng; Chen-Guang Zhao; Ju-Wei Mu
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

6.  The Prognostic Value of Log Odds of Positive Lymph Nodes in Early-Stage Esophageal Cancer Patients: A Study Based on the SEER Database and a Chinese Cohort.

Authors:  Kexing Xi; Wenyou Chen; Hui Yu
Journal:  J Oncol       Date:  2021-03-05       Impact factor: 4.375

7.  A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging.

Authors:  Xinye Li; Jinming Xu; Linhai Zhu; Sijia Yang; Li Yu; Wang Lv; Jian Hu
Journal:  Cancer Med       Date:  2021-06-15       Impact factor: 4.452

8.  Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction.

Authors:  Jinming Xu; Jinlin Cao; Luming Wang; Zhitian Wang; Yiqing Wang; Yihua Wu; Wang Lv; Jian Hu
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

9.  Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.

Authors:  Sujing Jiang; Lihao Zhao; Congying Xie; Huafang Su; Ye Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-07       Impact factor: 5.555

10.  Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010-2015).

Authors:  Yufeng Xu; Lixia Lou; Yijie Wang; Qi Miao; Kai Jin; Menglu Chen; Juan Ye
Journal:  J Ophthalmol       Date:  2020-02-19       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.